跳至主要内容
临床试验/NCT04001348
NCT04001348已完成不适用

A Single-blind, Randomized, Uni-centre Study to Determine the Characteristics of Different Types of Safety Lancets on Blood Volume and Perceived Pain in Male and Female Volunteers

HTL-Strefa S.A.2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
2
主要终点
Volume (microliters) of blood in the capillary tube

研究概览

简要总结

The study was a randomized, single blind, uni-center pivotal study in male and female healthy volunteers, to determine capillary blood volume and pain perception obtained in a process of puncturing with different safety lancets.

A group of one hundred (100) healthy Caucasian male and female Subjects (aged > 18 to < 65 years old was randomized ) who were in good physical and mental condition. The Subjects had 4 (four) fingers (two fingers from each hand) lanced each with a different type of safety lancet. Overall, 4 (four) different safety lancets were investigated per each Subject.

Overall, 16 (sixteen) different safety lancets (4 different safety lancets per one Subject) were investigated, the capillary blood volume and pain were measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing to sign the informed consent.
  • Male and female volunteers.
  • Age between 18 and 65 inclusive.
  • Able to communicate well with the Investigator and comply with the requirements of the study.
  • Volunteers who are in good physical and mental health.

排除标准

  • Pregnancy or breastfeeding (self-reported).
  • Confirmed or suspected malignant cancer History of poor blood circulation.
  • Any skin condition on his or her fingers that prevents blood sampling.
  • Anxiety with needles or finger pricks.
  • Clotting disorders (including bleeding) in medical history.
  • Neuropathy or other condition affecting sensation in the hands.
  • History of blood borne infection (e.g., HIV, hepatitis B or C, syphilis, malaria, babesiosis, brucellosis, leptospirosis, arboviral infections, relapsing fever, T lymphotropic virus Type 1, Creutzfeldt-Jakob disease).
  • Currently participating in another study.
  • History of drug or alcohol abuse within the 12 months prior to screening or evidence of such abuse.
  • Intake of alcohol within 48 hours prior to the start of the study (self-reporting).
  • Donation or loss of 400 mL or more of blood within 4 weeks prior to the start of the study.
  • Any other condition that in the Investigator opinion may negatively influence Subject's participation in the study.
  • Intake of medicines that affect blood coagulability (including anticoagulants such as vitamin K, antivirals and anticoagulants such as heparin, aspirin, thrombin inhibitors, vitamin K antagonists).

研究组 & 干预措施

HTL-STREFA S.A.safety lancet type 610

Experimental

干预措施: Acti-Lance Lite (Device)

HTL-STREFA S.A.safety lancet type 610

Experimental

干预措施: Acti-Lance Universal (Device)

HTL-STREFA S.A.safety lancet type 610

Experimental

干预措施: Acti-Lance Special (Device)

HTL-STREFA S.A.safety lancet type 553-556

Experimental

干预措施: Medlance Plus Super Lite (Device)

HTL-STREFA S.A.safety lancet type 553-556

Experimental

干预措施: Medlance Plus Lite (Device)

HTL-STREFA S.A.safety lancet type 553-556

Experimental

干预措施: Medlance Plus Universal (Device)

HTL-STREFA S.A.safety lancet type 553-556

Experimental

干预措施: Medlance Plus Extra (Device)

HTL-STREFA S.A.safety lancet type 553-556

Experimental

干预措施: Medlance Plus Special (Device)

HTL-STREFA S.A.safety lancet type 430

Experimental

干预措施: Prolance Micro Flow (Device)

HTL-STREFA S.A.safety lancet type 430

Experimental

干预措施: Prolance Low Flow (Device)

HTL-STREFA S.A.safety lancet type 430

Experimental

干预措施: Prolance Normal Flow (Device)

HTL-STREFA S.A.safety lancet type 430

Experimental

干预措施: Prolance High Flow (Device)

HTL-STREFA S.A.safety lancet type 430

Experimental

干预措施: Prolance Max Flow (Device)

HTL-STREFA S.A.safety lancet type 430

Experimental

干预措施: Prolance Pediatric (Device)

HTL-STREFA S.A.safety lancet type 520

Experimental

干预措施: MediSafe Solo 29 Gauge (Device)

HTL-STREFA S.A.safety lancet type 520

Experimental

干预措施: MediSafe Solo 23 Gauge (Device)

结局指标

主要结局

Volume (microliters) of blood in the capillary tube

时间窗: The blood from the puncture site was collected to the capillaries by pressing during 2 minutes

The amount of capillary blood volume collected after a single lancing of the fingertip.

次要结局

  • Pain perception: VAS(5 minutes after lancing)

研究者

发起方
HTL-Strefa S.A.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验